Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Eight women were postmenopausal but none had received hormone therapy (HT).Clinical characteristics and areal BMD of AS patients and non-AS subjectsVariableAS patientsNon-AS subjectsNumber5385Men (%)29 (55)*25 (29)Caucasians40 (75)*76 (89)Age (years)44 ± 12*61 ± 8Weight (kg)75 ± 376 ± 2Height (cm)167 ± 2164 ± 1BMI (kg/m2)27 (22 to 32)27 (25 to 31)Fragility fractures (%)5 (9)6 (11)Corticosteroid use (%)3 (6)5 (6)Bisphosphonate use (%)4 (9)13 (15)DMARDs (%)7 (13)0 (0)Total daily calcium intake (mg)745 (456 to 1020)*1045 (471 to 1539)Use of supplemental vitamin D (%)a 19 (36)32 (38)Hormone therapy (%)b 0 (0)*16 (19)Areal BMDc (g/cm2) L1: L40.994 ± 0.1790.988 ± 0.156 Total hip0.904 ± 0.1490.930 ± 0.123 Femoral neck0.767 ± 0.1420.756 ± 0.116 Distal 1/3 radius0.740 ± 0.1270.644 ± 0.170 Ultra distal radius0.477 ± 0.0780.418 ± 0.120 Low BMD/osteopenia (%)18 (34)37 (44) Osteoporosis (%)6 (11)7 (8)Data expressed as mean ± standard deviation, median (interquartile range) or number (% N) unless specified otherwise aAt least 1000 IU vitamin D bPostmenopausal women receiving hormone replacement treatment cIntergroup comparison of BMD was not performed between AS and non-AS subjects because of the differences in age and sex*p <0.05 AS ankylosing spondylitis, BMD bone mineral density, BMI body mass index, DMARD disease-modifying antirheumatic drug
Source: Demographic parameters. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis
Source: Article title.
Patients were recruited from the spondylitis clinic located at Toronto Western Hospital, Canada.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis
Cross-sectional study · Arthritis Research & Therapy · 2015
Original publication title
Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis
© Nigil Haroon et al. 2015
Original publication · Publisher record [link unavailable; original address: https://doi.org/10.1186/s13075-015-0873-1] · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Ankylosing spondylitis (AS) is an inflammatory disease associated with new bone formation and an increased risk of osteoporosis and fractures. The negative effects of AS on bone microarchitecture and strength are unclear. Thus, we conducted an observational study to analyze the effect of AS on bone microarchitecture and strength.
Source: IntroductionAbstract: What methods does the paper describe?
Patients with AS (n = 53) and non-AS subjects (n = 85) were recruited for the study. All subjects underwent clinical evaluation, DXA and high-resolution peripheral quantitative CT scans (HRpQCT).
Source: MethodsAbstract: Results
The AS patients were aged 44 ± 12 (mean ± standard deviation) years and had a median disease duration of 17 (interquartile range: 7 to 27) years. They were found to have lower cortical, trabecular and total vBMD at the distal radius and tibia than non-AS subjects on multivariable regression analysis. Cortical parameters such as cortical thickness and porosity, and bone strength parameters such bone stiffness and stress as estimated by finite element analysis (FEA) in AS patients were significantly worse than that of-non-AS subjects.
Among patients with AS, male sex, mSASSS greater than zero and HLA-B27 negative status were associated with worse bone microarchitecture.
Source: ResultsAbstract: Conclusions
Patients with AS have worse bone mineral density, microarchitecture and strength when compared to non-AS subjects. More research is needed to understand the mechanisms underlying bone pathology in AS and to assess the effect of treatments such as TNF inhibitors on bone quality and fracture risk.
Source: ConclusionsAuthors’ abstract
Introduction
Ankylosing spondylitis (AS) is an inflammatory disease associated with new bone formation and an increased risk of osteoporosis and fractures. The negative effects of AS on bone microarchitecture and strength are unclear. Thus, we conducted an observational study to analyze the effect of AS on bone microarchitecture and strength.
Methods
Patients with AS (n = 53) and non-AS subjects (n = 85) were recruited for the study. All subjects underwent clinical evaluation, DXA and high-resolution peripheral quantitative CT scans (HRpQCT).
Results
The AS patients were aged 44 ± 12 (mean ± standard deviation) years and had a median disease duration of 17 (interquartile range: 7 to 27) years. They were found to have lower cortical, trabecular and total vBMD at the distal radius and tibia than non-AS subjects on multivariable regression analysis. Cortical parameters such as cortical thickness and porosity, and bone strength parameters such bone stiffness and stress as estimated by finite element analysis (FEA) in AS patients were significantly worse than that of-non-AS subjects.
Among patients with AS, male sex, mSASSS greater than zero and HLA-B27 negative status were associated with worse bone microarchitecture.
Conclusions
Patients with AS have worse bone mineral density, microarchitecture and strength when compared to non-AS subjects. More research is needed to understand the mechanisms underlying bone pathology in AS and to assess the effect of treatments such as TNF inhibitors on bone quality and fracture risk.
Publication and source details
Original title: Alterations of bone mineral density, bone microarchitecture and strength in patients with ankylosing spondylitis: a cross-sectional study using high-resolution peripheral quantitative computerized tomography and finite element analysis
Nisha Nigil Haroon; Eva Szabo; Janet M. Raboud; Heather Mcdonald-Blumer; Lydia Fung; Robert G. Josse; Robert D. Inman; Angela M. Cheung
Arthritis Research & Therapy · 2015
© Nigil Haroon et al. 2015https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Amgen CanadaOur study was funded through an investigator initiated research grant from AMGEN. However AMGEN had no role in the design of the study, the conduct of the analysis, interpretation of results or the preparation of the manuscript.Inman Robert D.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T20:13:49.773812+00:00
DOI: 10.1186/s13075-015-0873-1 · PMC4718021